Novartis AG
COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC RETINOPATHY
Last updated:
Abstract:
The present invention provides compounds and methods for the treatment of diabetic retinopathy. In particular, LFA-1 antagonists are described herein to be used in the treatment of diabetic retinopathy. One aspect of the invention provides for diagnosis of diabetic retinopathy and administration of a LFA-1 antagonist, after the patient is diagnosed with diabetic retinopathy.
Status:
Application
Type:
Utility
Filling date:
22 Feb 2021
Issue date:
4 Nov 2021